Placebo
HALO-109-301
Phase 3 small_molecule terminated
Quick answer
Placebo for Pancreatic Ductal Carcinoma is a Phase 3 program (small_molecule) at HALOZYME THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- HALOZYME THERAPEUTICS, INC.
- Indication
- Pancreatic Ductal Carcinoma
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated